Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Daniella Okyere, Laura Bravo-Merodio, Yuanwei Xu, Durga Parkhi, Georgios V. Gkoutos, Animesh Acharjee
Abstract
Authors
Institutions
Computational approaches in rheumatic diseases – Deciphering complex spatio-temporal cell interactions
2023 · 8 citations
Multimodal analysis methods in predictive biomedicine
2023 · 0 citations
Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response
2023 · 0 citations
No local citing links have been materialized yet.
10.1016/j.gpb.2016.03.008
10.1016/j.gpb.2016.03.008
Machine learning approaches to drug response prediction: challenges and recent progress
2020
A performance evaluation of drug response prediction models for individual drugs
10.1038/s41598-023-39179-2 · 2023
Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
10.3389/fmed.2023.1086097 · 2023
Unresolved referenced work
2018
10.1007/978-3-030-62080-6_4
10.1007/978-3-030-62080-6_4
10.1111/cts.12884
10.1111/cts.12884
10.1038/s41573-022-00579-0
10.1038/s41573-022-00579-0
10.3390/cancers15164026
10.3390/cancers15164026
10.1186/s12943-021-01441-4
10.1186/s12943-021-01441-4
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells |
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1093/nar/gks1111 · 2013
Human genome meeting 2016
10.1186/s40246-016-0063-5 · 2016
10.1126/science.1132939
10.1126/science.1132939
10.1038/nature11003
10.1038/nature11003
10.1016/j.cell.2017.06.010
10.1016/j.cell.2017.06.010
10.1016/j.cell.2020.03.053
10.1016/j.cell.2020.03.053
10.1016/j.csbj.2023.06.008
10.1016/j.csbj.2023.06.008
10.1038/nature10983
10.1038/nature10983
Survival Analysis Part I: Basic concepts and first analyses
10.1038/sj.bjc.6601118 · 2003
10.1023/a:1010933404324
10.1023/a:1010933404324
10.1023/a:1022627411411
10.1023/a:1022627411411
10.1093/bioinformatics/btz318
10.1093/bioinformatics/btz318
Deep generative neural network for accurate drug response imputation
10.1038/s41467-021-21997-5 · 2021
Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
10.1038/s41598-018-27214-6 · 2018
Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network
10.1186/s12859-019-2910-6 · 2019
TGSA: protein–protein association-based twin graph neural networks for drug response prediction with similarity augmentation
10.1093/bioinformatics/btab650 · 2022
Graph Convolutional Networks for Drug Response Prediction
10.1109/tcbb.2021.3060430 · 2022
DualGCN: a dual graph convolutional network model to predict cancer drug response
10.1186/s12859-022-04664-4 · 2022
Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions
10.1093/bioinformatics/btac574 · 2022
10.1016/j.apsb.2025.05.009
10.1016/j.apsb.2025.05.009
Applications of AI in Predicting Drug Responses for Type 2 Diabetes
10.2196/66831 · 2025
10.1186/s12943-025-02321-x
10.1186/s12943-025-02321-x
10.1093/carcin/bgx085
10.1093/carcin/bgx085
An overview of machine learning methods for monotherapy drug response prediction
10.1093/bib/bbab408 · 2022
Artificial intelligence approaches for molecular representation in drug response prediction
10.1016/j.sbi.2023.102747 · 2024
10.1016/j.sbi.2023.102745
10.1016/j.sbi.2023.102745
10.3390/life13091878
10.3390/life13091878
A review of machine learning approaches for drug synergy prediction in cancer
10.1093/bib/bbac075 · 2022
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
2024
10.1016/j.csbj.2024.05.011
10.1016/j.csbj.2024.05.011
10.3390/math11081777
10.3390/math11081777 · doi-reference
Graph neural networks: A review of methods and applications
10.1016/j.aiopen.2021.01.001 · doi-reference
Graph neural networks
10.1038/s43586-024-00294-7 · doi-reference
10.1038/s41592-023-01973-1
10.1038/s41592-023-01973-1 · doi-reference
10.1186/s40537-021-00444-8
10.1186/s40537-021-00444-8 · doi-reference
Autoencoders and their applications in machine learning: a survey
10.1007/s10462-023-10662-6 · doi-reference
Neural networks primer
10.1038/s41592-022-01747-1 · doi-reference
10.1038/nbt1206-1565
10.1038/nbt1206-1565 · doi-reference
A comprehensive survey on support vector machine classification: Applications, challenges and trends
10.1016/j.neucom.2019.10.118 · doi-reference
Principal component analysis
10.1038/s43586-022-00184-w · doi-reference
Statistics review 6: Nonparametric methods
10.1186/cc1820 · doi-reference
10.1186/cc3045
10.1186/cc3045 · doi-reference
A multimodal LLM-agent framework for personalized clinical decision-making in hepatocellular carcinoma
10.1016/j.patter.2025.101364 · doi-reference
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
10.1186/s41231-019-0050-7 · doi-reference
10.3389/fmicb.2023.1274925
10.3389/fmicb.2023.1274925 · doi-reference
Pharmaco-metabolomics opportunities in drug development and clinical research
10.1002/ansa.202000178 · doi-reference
10.3390/metabo14020098
10.3390/metabo14020098 · doi-reference
10.3390/jpm8030028
10.3390/jpm8030028 · doi-reference
Pan-cancer proteomic map of 949 human cell lines
10.1016/j.ccell.2022.06.010 · doi-reference
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
10.1038/s41467-021-22170-8 · doi-reference
Opportunities for pharmacoproteomics in biomarker discovery
10.1002/pmic.202200031 · doi-reference
10.1016/j.cell.2016.06.017
10.1016/j.cell.2016.06.017 · doi-reference
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
10.1093/bioinformatics/btw449 · doi-reference
10.1093/bib/bbz164
10.1093/bib/bbz164 · doi-reference
Transforming Clinical Research: The Power of High-Throughput Omics Integration
10.3390/proteomes12030025 · doi-reference
Predicting risk of adverse drug reactions in older adults
10.1177/2042098615615472 · doi-reference
10.1145/3394486.3411074
10.1145/3394486.3411074 · doi-reference
Health data poverty: an assailable barrier to equitable digital health care
10.1016/s2589-7500(20)30317-4 · doi-reference
10.3390/biomedicines12071496
10.3390/biomedicines12071496 · doi-reference
10.1186/1752-0509-8-s2-i1
10.1186/1752-0509-8-s2-i1 · doi-reference
10.1038/s12276-018-0071-8
10.1038/s12276-018-0071-8 · doi-reference
Overcoming limitations in current measures of drug response may enable AI-driven precision oncology
10.1038/s41698-024-00583-0 · doi-reference
10.1038/srep05193
10.1038/srep05193 · doi-reference
10.1016/j.coisb.2018.07.001
10.1016/j.coisb.2018.07.001 · doi-reference
10.1002/jcc.24764
10.1002/jcc.24764 · doi-reference
10.1093/bib/bbz171
10.1093/bib/bbz171 · doi-reference
10.1109/tnnls.2020.2978386
10.1109/tnnls.2020.2978386 · doi-reference
Should we really use graph neural networks for transcriptomic prediction?
10.1093/bib/bbae027 · doi-reference
10.1007/0-387-25465-x_40
10.1007/0-387-25465-x_40 · doi-reference
Class prediction for high-dimensional class-imbalanced data
10.1186/1471-2105-11-523 · doi-reference